News Image

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Feb 27, 2025

Commercial Preparations On-Track Ahead of September 25, 2025 PDUFA Date Including Regulatory Review Process, Organizational Build, and Key Stakeholder Engagement Efforts

Read more at globenewswire.com

CRINETICS PHARMACEUTICALS IN

NASDAQ:CRNX (6/10/2025, 8:00:01 PM)

After market: 33.08 0 (0%)

33.08

+0.8 (+2.48%)



Find more stocks in the Stock Screener

Follow ChartMill for more